- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
Taxpayers must pay the freight for over-budget train projects
Topic - Francis S. Collins
The National Institute of Health on Tuesday announced a partnership with a handful of major drug companies on a project to dramatically reduce the time it takes to create and market medications that treat debilitating diseases.
The U.S. National Institutes of Health, 10 drugmakers and several disease foundations are starting an unusual project to find and bring new medicines, particularly for complex, expensive chronic diseases, to patients more quickly and for less money.
The federal government said Wednesday it will send 310 chimpanzees into early retirement because of new opinions on whether it's moral to use the prized primates for biomedical research.
Naomi Judd's new limited-run SiriusXM radio talk show has no safety net, and even the country star isn't sure that's a great idea.
The United States will fund training for 140,000 African health care workers in an initiative to "transform and dramatically increase" medical education on the continent, the top U.S. AIDS official announced Tuesday.
The phrase "embryonic stem cell research" puts a scientist's gloss on what really happens: Our smallest humans, embryos, become subjects for experimentation. And when they've served their purpose, they're done for. Living beings, now dead.
Sen. Arlen Specter said Thursday that Congress should "get busy" on giving legal stature to the federal funding of human embryonic stem cell research to avoid giving a final say on the issue to a conservative Supreme Court.
"We are going to try to increase the odds of picking the right targets to go after for the next generations of drug developers," NIH Director Dr. Francis S. Collins said.
Dr. Collins said that too often drugs are found to be ineffective in the late stages of development — after years of work and millions of dollars in research and testing — because scientists chose the wrong biological targets.